ArticleCancer research and treatment2024

A Nationwide Study on HER2-Low Breast Cancer in South Korea: Its Incidence of 2022 Real World Data and the Importance of Immunohistochemical Staining Protocols.

Min Chong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.